Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx
Clinical trial NCT04935177 · COMPLETED
Trial details
- NCT number
- NCT04935177
- Sponsor
- Hansa Biopharma AB
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-14
- Primary completion
- 2025-06-20
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.